Humana's stock was upgraded to Outperform by Evercore ISI following strong Q2 2026 results. The company reported adjusted earnings of $7.61 per share and revenues of $40.9 billion, both exceeding analyst expectations, driven by a 20.7% growth in medical membership to 17.9 million. Despite a rising benefit ratio indicating higher medical costs, Humana maintained its 2026 profit outlook of at least $9 per share. Some analysts were disappointed the profit forecast was not raised, but the upgrade reflects confidence in Humana's performance and growth prospects.
Humana reported second-quarter earnings that exceeded analyst expectations, with adjusted earnings per share of $7.61 versus the expected $7.22, and revenue of $40.87 billion beating estimates. The company maintained its 2026 adjusted profit outlook ...
Humana reported a second-quarter net income of $694 million, driven by a surge in Medicare Advantage enrollees to 7.1 million, up from 5.8 million a year ago. Despite rising medical costs industry-wide, Humana managed to keep its benefit ratio at 91....
A securities fraud lawsuit against Humana Inc. and its former CEO and CFO is proceeding after a judge ruled key claims valid. The lawsuit alleges that from July 2022 to October 2024, Humana misled investors about rising healthcare utilization costs, ...
This week, U.S. markets focus on the Federal Reserve's July meeting, key inflation data like Core PCE, and second-quarter GDP figures, alongside major tech earnings from Microsoft, Meta, Apple, and Amazon. Rising oil prices and geopolitical tensions ...
